Aidwell Limited is a privately held limited company established in 1979, operating from its headquarters at 6 Elystan Street, London, SW3 3NS. The company’s SIC codes indicate its primary focus on the wholesale distribution of pharmaceutical goods within the United Kingdom and internationally. Aidwell specializes in providing a comprehensive range of pharmaceutical products to various sectors, including pharmacies, hospitals, and specialist stores. As a registered company with the Securities and Exchange Commission (SIC) code 01444333, Aidwell Limited maintains a stable operational status. The company’s core business revolves around the sourcing, storage, and distribution of a diverse portfolio of medications, encompassing both generic and specialized formulations. Aidwell Limited’s international presence is currently acknowledged as ‘yes’, with a focus on establishing strategic partnerships across Europe and North America. The company’s size is estimated to be relatively small, reflecting its specialized market focus. Aidwell Limited’s key focus is on maintaining a robust supply chain and ensuring timely delivery of pharmaceutical products. The company employs a skilled workforce and is actively seeking to expand its international reach. Further details regarding financial performance and corporate governance are available upon request.

Aidwell Limited is a privately held limited company established in 1979, operating from its headquarters at 6 Elystan Street, London, SW3 3NS. The company’s SIC codes indicate its primary focus on the wholesale distribution of pharmaceutical goods within the United Kingdom and internationally. Aidwell specializes in providing a comprehensive range of pharmaceutical products to various sectors, including pharmacies, hospitals, and specialist stores. As a registered company with the Securities and Exchange Commission (SIC) code 01444333, Aidwell Limited maintains a stable operational status. The company’s core business revolves around the sourcing, storage, and distribution of a diverse portfolio of medications, encompassing both generic and specialized formulations. Aidwell Limited’s international presence is currently acknowledged as ‘yes’, with a focus on establishing strategic partnerships across Europe and North America. The company’s size is estimated to be relatively small, reflecting its specialized market focus. Aidwell Limited’s key focus is on maintaining a robust supply chain and ensuring timely delivery of pharmaceutical products. The company employs a skilled workforce and is actively seeking to expand its international reach. Further details regarding financial performance and corporate governance are available upon request.